Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Shen, Wei ^a   Wang, Chun Yi ^a   Wang, Xue Hu ^a   Fu, Zhong Xue ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA; ONCOLYTIC ADENOVIRUS; SHORT HAIRPIN RNA; SURVIVIN; BIRC5 PROTEIN, HUMAN; GREEN FLUORESCENT PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; SURVIVIN PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GENE CONSTRUCT; GENE EXPRESSION; GENE REPLICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR VOLUME; WESTERN BLOTTING; XENOGRAFT; ADENOVIRUS; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; COLON TUMOR; GENETICS; METABOLISM; ONCOLYTIC VIROTHERAPY; PHYSIOLOGY; VIROLOGY;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; COLONIC NEOPLASMS; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MICE, INBRED BALB C; MICROTUBULE-ASSOCIATED PROTEINS; ONCOLYTIC VIROTHERAPY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER;

EID: 68149160020     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-81     Document Type: Article

References (33)

1. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078 (Pubitemid 40372904)
2. Structural, functional and therapeutic biology of Survivin. NK Sah Z Khan GJ Khan PS Bisen, Cancer Lett. 2006 244 2 164 171 10.1016/j.canlet.2006.03.007 16621243
3. A noble anti-apoptotic gene, Survivin, is expressed in cancer and lymphoma. G Ambrosini C Adida DC Altieri, Nat. Med 1997 3 917 921 10.1038/nm0897-917 9256286
4. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. NS Williams RB Gaynor S Scoggin U Verma T Gokaslan C Simmang J Fleming D Tavana E Frenkel Cl Becerra, Clin Cancer Res 2003 9 931 46 12631590
5. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist. H Yan J Thomas T Liu D Raj N London T Tandeski SA Leachman RM Lee D Grossman, Oncogene 2006 25 6968 74 16702945 10.1038/sj.onc.1209676
6. Use of siRNAs and antisense oligonucleotides against Survivin RNA to inhibit steps leading to tumor angiogenesis. S Coma, Oligonucleotides 2004 14 100 1351 10.1089/1545457041526290 15294074
7. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. H Uchida, Mol Ther 2004 10 162 71 10.1016/j.ymthe.2004.05.006 15233951
8. Survivin as a target for new anticancer interventions. N Zaffaroni M Pennati MG Daidone, J Cell Mol Med 2005 9 360 72 10.1111/j.1582-4934.2005. tb00361.x 15963255
9. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. FR Khuri, Nat Med 2000 6 879 85 10.1038/78638 10932224
10. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. C Heise A Sampson-Johannes A Williams F McCormick DD Von Hoff DH Kirn, Nat Med 1997 3 639 45 10.1038/nm0697-639 9176490
11. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. ZL Zhang WG Zou CX Luo BH Li JH Wang LY Sun QJ Qian XY Liu, Cell Res 2003 13 481 9 10.1038/sj.cr.7290191 14728805
12. Cancer statistics, 2008. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun, CA Cancer J Clin 2008 58 71 96 10.3322/CA.2007.0010 18287387
13. Abnoba-viscum (mistletoe extract) in metastatic colorectal carcinoma resistant to 5-fluorouracil and leucovorin-based chemotherapy. G Bar-Sela N Haim, Med Oncol 2004 21 251 4 10.1385/MO:21:3:251 15456952
14. Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. BM Bernhardson C Tishelman LE Rutqvist, J Pain Symptom Manage 2007 34 403 12 10.1016/j.jpainsymman.2006.12.010 17616338
15. Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases. J Joosten G Jager W Oyen T Wobbes T Ruers, Eur J Surg Oncol 2005 31 1152 9 10.1016/j.ejso.2005.07.010 16126363
16. Surgical resection of a solitary pancreatic metastasis from colorectal cancer: a new step to a cure? C Gravalos L García-Sanchez M Hernandez E Holgado N Alvarez I García-Escobar J Martínez L Robles, Clin Colorectal Cancer 2008 7 398 401 10.3816/CCC.2008.n.053 19036693
17. Trends in chemotherapy utilization for colorectal cancer. D Renouf H Kennecke S Gill, Clin Colorectal Cancer 2008 7 386 9 10.3816/CCC.2008.n.051 19036691
18. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. C Pozzo M Basso A Cassano M Quirino G Schinzari N Trigila M Vellone F Giuliante G Nuzzo C Barone, Ann Oncol 2004 15 933 9 10.1093/annonc/mdh217 15151951
19. Breakthrough of the year. Small RNAs make big splash. J Couzin, Science. 2002 20 298 2296 2297 10.1126/science.298.5602.2296
20. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells. T Chen C Deng, Int Immunopharmacol 2008 8 1006 11 10.1016/j.intimp.2008. 03.004 18486912
21. Short hairpin RNA targeting survivin inhibits growth and angiogenesis of glioma U251 cells. HN Zhen LW Li W Zhang Z Fei CH Shi TT Yang WT Bai X Zhang, Int J Oncol 2007 31 1111 7 17912437
22. Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers. QX Li, Cancer Biol Ther 2006 5 860 6 16861916
23. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. BS Sun, Hepatology 2008 48 1834 42 10.1002/hep.22531 18972404
24. Cyclooxygenase-2 knockdown by RNA interference in colon cancer. GS Charames B Bapat, Int J Oncol 2006 28 543 9 16391811
25. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis. PY Wai Z Mi H Guo S Sarraf-Yazdi C Gao J Wei CE Marroquin B Clary PC Kuo, Carcinogenesis 2005 26 741 51 10.1093/carcin/bgi027 15661802
26. Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy. KF Hsu CL Wu SC Huang JL Hsieh YS Huang YF Chen MR Shen WJ Chung CY Chou AL Shiau, Cancer Gene Ther 2008 15 526 34 10.1038/cgt.2008.37 18497852
27. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. JR Bischoff, Science 1996 274 373 6 10.1126/science.274.5286.373 8832876
28. Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy. CC Heise AM Williams S Xue M Propst DH Kirn, Cancer Res 1999 59 2623 8 10363984
29. Gene therapy progress and prospects cancer: oncolytic viruses. TC Liu D Kirn, Gene Ther 2008 15 877 84 10.1038/gt.2008.72 18418413
30. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase. O Wildner RM Blaese JC Morris, Cancer Res 1999 15 59 410 3
31. Treatment of hepatocellular carcinoma by AdAFPep/rep, AdAFPep/p53, and 5-fluorouracil in mice. T Sagawa, Hepatology 2008 48 828 40 10.1002/hep.22420 18756484
32. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA. JN Zheng DS Pei LJ Mao XY Liu DD Mei BF Zhang Z Shi RM Wen XQ Sun, Cancer Gene Ther 2009 16 20 32 10.1038/cgt.2008.61 18690204
33. Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carring MDA-7/IL-24. YM Wu KJ Zhang XT Yue YQ Wang Y Yang GC Li N Li YG Wang, Acta Pharmacol Sin 2009 30 467 477 10.1038/aps.2009.16 19270721